Jennifer Butler, MD
Family Medicine · Souderton, PANPI 1447253489
Payments from drug & device makers
Across 296 payments — averaging $16.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$979
- Amgen$590
- AbbVie$451
- AstraZeneca$434
- Pfizer$432
- Astellas Pharma US Inc$350
- plus $2K from 25 others
What the payments were for
- Food & beverage$4,935100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 59 | $979 |
| Amgen | 33 | $590 |
| AbbVie(2 entities) | 26 | $451 |
| AstraZeneca | 28 | $434 |
| Pfizer | 31 | $432 |
| Astellas Pharma US Inc | 19 | $350 |
| GSK | 17 | $288 |
| Lilly USA, LLC | 13 | $243 |
| Johnson & Johnson | 10 | $168 |
| Merck | 12 | $160 |
| Exact Sciences | 6 | $143 |
| Abbott | 6 | $102 |
| Bayer | 6 | $84 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $69 |
| Boehringer Ingelheim | 4 | $63 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $42 |
| Daiichi Sankyo Inc. | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Sanofi Pasteur Inc. | 2 | $34 |
| Lundbeck LLC | 2 | $34 |
| IBSA Pharma Inc. | 1 | $24 |
| Jazz Pharmaceuticals Inc. | 1 | $24 |
| Beigene USA, Inc. | 1 | $24 |
| Vertos Medical, Inc. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $16 |
| Beone Medicines USA, Inc. | 1 | $15 |
| Dynavax Technologies Corporation | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
How this compares
$4,935 in reported general payments places this provider in the 85th percentile of 4,967 family medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 55 | $97,071 |
| FarxigaDapagliflozin Propanediol | 40 | $58,601 |
| JardianceEmpagliflozin | 46 | $47,634 |
| MounjaroTirzepatide | 18 | $32,465 |
| XareltoRivaroxaban | 25 | $24,788 |
| MyrbetriqMirabegron | 18 | $20,535 |
| TrulicityDulaglutide | 18 | $19,094 |
| EliquisApixaban | 22 | $13,291 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 13 | $7,167 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 13 | $5,948 |
| Arnuity ElliptaFluticasone Furoate | 16 | $2,998 |
| Atorvastatin Calcium | 259 | $2,719 |
| Metformin Hcl ErMetformin Hcl | 156 | $2,595 |
| SynthroidLevothyroxine Sodium | 28 | $2,506 |
| Levothyroxine Sodium | 177 | $2,383 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $979 | $97,07155 claims |
| AstraZenecaFarxiga | $434 | $58,60140 claims |
| Lilly USA, LLCMounjaro, Trulicity | $243 | $51,55936 claims |
| Boehringer IngelheimJardiance | $63 | $47,63446 claims |
| Johnson & JohnsonXarelto | $168 | $24,78825 claims |
| Astellas Pharma US IncMyrbetriq | $350 | $20,53518 claims |
| PfizerEliquis | $432 | $13,29122 claims |
| GSKAnoro Ellipta, Arnuity Ellipta | $288 | $8,94629 claims |
| MerckJanumet Xr | $160 | $7,16713 claims |
| AbbVieSynthroid | $451 | $2,50628 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in Souderton
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
- Bryce PalchickPittsburgh$4.7M
- Harris CohenHorsham$3.7M
- Shari RozenPittsburgh$2.9M
- Richard CookUniontown$2.1M
- Bruce GebhardtErie$2.1M
- Peter CognettiScranton$1.9M
- Bradley FoxErie$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.